⚖️ Weight Management · Apgujeong Hana Clinic
Wegovy Clinic Seoul
English-friendly Wegovy consultation with a board-certified endocrinologist in Gangnam—covering medical eligibility, semaglutide injection guidance, gradual dose titration, side-effect monitoring and long-term weight management.
✓
Medical eligibility review
✓
Weekly injection guidance
✓
English monitoring
Weekly Treatment Pathway
Start low, increase gradually and monitor tolerance
Once-weekly injection
01
Starting Phase
Introduce treatment at a low dose
02
Early Increase
Review nausea and eating tolerance
03
Mid Titration
Assess appetite and hydration
04
Higher Dose
Continue only when well tolerated
05
Maintenance
Individual dose and follow-up plan
APPETITE
Hunger, fullness and food intake
TOLERANCE
Nausea, vomiting and bowel symptoms
HEALTH
Weight and metabolic markers
FOLLOW-UP
Dose review and maintenance
This is a general treatment pathway—not a self-dosing guide. The prescribed dose and escalation schedule depend on local product information, medical history, availability and individual tolerance.
🩺
Consultation Required
Wegovy is prescribed only after individual medical and safety assessment.
💉
Weekly Semaglutide
The injectable treatment is generally administered once each week.
📈
Gradual Titration
The dose is usually increased gradually rather than starting at maintenance level.
🔄
Ongoing Monitoring
Appetite, weight, side effects and health markers are reviewed over time.
✓
Board-Certified Endocrinologist
✓
Wegovy Prescription Assessment
✓
English Injection Guidance
✓
Apgujeong · Gangnam
What Is Wegovy?
Wegovy is prescription semaglutide for long-term weight management.
Wegovy belongs to a medication class called GLP-1 receptor agonists. It is used alongside a reduced-calorie eating plan and increased physical activity in patients who meet the relevant medical criteria.
Semaglutide acts on pathways involved in appetite and food intake. Many patients feel fuller sooner or experience less hunger, but individual response and tolerance vary.
At Apgujeong Hana Clinic, Wegovy assessment is led by Dr. Shin Hyun-won, a board-certified endocrinologist and internal-medicine specialist. Consultation, injection education and follow-up are available in English.
🧬
GLP-1 Receptor Agonist
Semaglutide acts on GLP-1 pathways involved in appetite, fullness and glucose regulation.
📅
Weekly Injection
The injection is generally used on the same day each week according to the prescription.
📊
Long-Term Treatment
Wegovy is designed for ongoing weight management rather than a rapid temporary diet.
🥗
Combined Approach
Medication works as part of a broader plan that includes nutrition, activity and follow-up.
Who May Be Eligible?
Eligibility is based on weight-related health risk—not appearance alone.
Common prescribing criteria consider BMI together with weight-related conditions. Korean prescribing requirements and your individual medical profile determine whether Wegovy is appropriate.
Adults With Obesity
Wegovy may be considered for adults whose BMI meets the applicable obesity-treatment criteria after medical assessment.
Overweight With Health Risks
Selected adults with overweight and a weight-related condition—such as hypertension, dyslipidaemia or glucose problems—may qualify.
Previous Weight Regain
Medical treatment may be discussed when structured lifestyle approaches have not produced sufficient or sustainable progress.
Prediabetes or Metabolic Risk
Weight management may form part of a broader plan for glucose risk, fatty liver or metabolic syndrome.
Weight-Related Sleep Apnoea
Sleep symptoms and diagnosed sleep apnoea may be considered when evaluating weight-related health burden.
International Patients
Patients living in Seoul can receive the consultation, prescription explanation and monitoring plan in English.
A Wegovy prescription is not guaranteed before consultation
The endocrinologist must assess eligibility, contraindications, current medicines, pregnancy plans, medical history and whether a different treatment would be safer or more appropriate.
Before Starting Wegovy
The consultation checks whether treatment is appropriate and safe.
🩺
Wegovy is one part of a medical weight-management plan.
The assessment reviews your weight history, health risks, previous treatment, current medicines and the practical support needed to use a weekly injection safely.
📋
Weight History
Previous weight changes, diets, medications, regain and current treatment goals are reviewed.
💊
Medicine Review
Tell the doctor about diabetes medicine, insulin, other GLP-1 drugs, supplements and all prescriptions.
🧬
Thyroid Cancer History
Personal or family history of medullary thyroid carcinoma or MEN2 requires specific safety review.
🥣
Digestive History
Pancreatitis, gallbladder disease, severe stomach-emptying problems and persistent digestive symptoms are discussed.
🩸
Diabetes & Eye Health
Glucose treatment and diabetic retinopathy history may affect monitoring and medication adjustment.
🤰
Pregnancy Plans
Wegovy is not used for weight loss during pregnancy, and planned pregnancy requires advance discussion.
How Semaglutide Supports Weight Management
Wegovy affects appetite-related pathways while lifestyle care supports long-term progress.
🧠
Appetite Signalling
Semaglutide acts on GLP-1 receptors involved in hunger, fullness and food-intake regulation.
🍽️
Earlier Fullness
Some patients feel satisfied with smaller portions or experience fewer appetite-driven eating episodes.
🩸
Glucose Effects
Semaglutide influences glucose-dependent insulin and glucagon responses, which is important when diabetes medicines are also used.
⏳
Digestive Effects
Delayed stomach emptying can contribute to fullness and also explains some digestive side effects and procedure precautions.
Wegovy Dose Titration
Treatment usually begins at a low dose and increases gradually.
A commonly used injectable pathway moves through 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and an individually selected maintenance dose. Do not change dose or timing without the prescribing doctor.
0.25
STARTING DOSE
Introduction Phase
The initial dose helps the body adjust. It is not intended to be the final maintenance dose.
0.5
EARLY TITRATION
Tolerance Review
Nausea, vomiting, hydration, constipation and eating tolerance are reviewed before further increase.
1.0
MID TITRATION
Response Assessment
Appetite response, injection routine and relevant glucose-treatment changes are considered.
1.7
HIGHER DOSE
Clinical Review
The next step may be delayed when side effects remain significant or intake is inadequate.
RX
MAINTENANCE
Individualised Dose
The clinician selects the appropriate maintenance plan using local labelling, response and tolerance.
Increasing faster does not mean better or safer results
Gradual titration is intended to improve tolerability. The prescribing doctor may pause escalation, continue a lower dose temporarily or reconsider treatment when side effects are difficult to manage.
Common Side Effects
Digestive symptoms are common, especially while the dose is increasing.
🥣
Report symptoms that interfere with eating or drinking.
Side effects may improve as the body adapts, but persistent vomiting, dehydration, severe pain or inability to maintain nutrition requires medical advice.
Nausea
Nausea is common during initiation or dose escalation and may be affected by meal size and food choices.
Vomiting
Repeated vomiting can cause dehydration and may require treatment review or delayed dose escalation.
Diarrhea
Loose or frequent stool may occur, particularly during the early treatment period.
Constipation
Reduced intake and slower digestive movement may contribute to difficult or infrequent bowel movements.
Abdominal Discomfort
Bloating, fullness, indigestion, belching or abdominal discomfort may occur.
Fatigue or Dizziness
Reduced intake, dehydration, glucose changes or another cause may contribute and should be assessed when persistent.
Important Safety Review
Some histories require avoidance, additional monitoring or a different treatment.
📋 Tell The Doctor Before Treatment
✓
All prescription medicines, supplements and other weight-loss products.
✓
Diabetes medicines, insulin or drugs that may cause low blood sugar.
✓
Previous pancreatitis, gallstones or gallbladder disease.
✓
Kidney problems, dehydration or repeated vomiting.
✓
Diabetic retinopathy, severe digestive disease or planned surgery.
⚠️ Wegovy May Not Be Appropriate
!
During pregnancy or when actively trying to become pregnant.
!
With personal or family history of medullary thyroid carcinoma.
!
With Multiple Endocrine Neoplasia syndrome type 2.
!
With a serious allergy to semaglutide or product ingredients.
!
Together with another semaglutide product or another GLP-1 medicine unless specifically directed.
Tell your surgical or endoscopy team that you use Wegovy
Semaglutide can delay stomach emptying. The procedure team needs this information before sedation, anaesthesia, gastroscopy, colonoscopy or surgery so they can provide appropriate medication and fasting instructions.
Seek Prompt Medical Advice
Severe or persistent symptoms should not be managed by simply skipping meals.
🤕
Severe Abdominal Pain
Persistent severe pain—especially when it spreads toward the back or occurs with vomiting—requires urgent assessment.
🤮
Repeated Vomiting
Contact the clinic when vomiting prevents you from keeping down fluids or prescribed medicines.
💧
Possible Dehydration
Marked dizziness, fainting, minimal urination, confusion or severe weakness requires prompt medical review.
🟡
Gallbladder Symptoms
Upper-right abdominal pain, fever, jaundice or pale stool may indicate a gallbladder problem.
👁️
Vision Changes
Patients with diabetes should report new or worsening visual symptoms promptly.
🚨
Allergic Reaction
Facial swelling, breathing difficulty, widespread rash or another serious allergic reaction requires emergency care.
Supporting Treatment
Wegovy works best within a complete weight-management strategy.
🥗
Nutrition
Food guidance supports adequate protein, fibre, hydration and smaller balanced meals without extreme restriction.
🏋️
Muscle Preservation
Resistance activity and sufficient nutrition help protect strength and lean tissue during weight loss.
🚶
Regular Movement
Walking, aerobic activity and reduced sedentary time are progressed according to current ability.
🌙
Sleep
Sleep duration, snoring and possible sleep apnoea may affect appetite, energy and long-term risk.
💧
Hydration
Adequate fluid intake is particularly important when nausea, vomiting, diarrhea or constipation occurs.
🔄
Maintenance Planning
Long-term care addresses plateaus, medication continuation, weight regain and sustainable routines.
Your Wegovy Clinic Visit
How consultation, prescription and follow-up work.
1
Book In English
Contact the clinic by WhatsApp, phone or Naver and mention that you need a Wegovy eligibility consultation.
2
Medical Assessment
Review weight history, BMI, health risks, current medicine, contraindications and relevant laboratory results.
3
Prescription & Training
When clinically appropriate and available, receive prescription instructions and injection education in English.
4
Titration & Follow-Up
Review appetite, weight, side effects, dose progression, nutrition and the long-term treatment plan.
Apgujeong, Gangnam
Wegovy consultation with an English-speaking endocrinologist.
Dr. Shin Hyun-won provides direct specialist assessment for obesity, metabolic health and GLP-1-based weight management.
📍
328 Apgujeong-ro, Gangnam-gu, Seoul, KFC Building 3F
🕘
Monday–Friday 09:00–19:00
🗓️
Saturday 09:00–13:00
📞
02) 3443-7550
⚕️
Dr. Shin Hyun-won
Board-certified endocrinologist and internal-medicine specialist with more than 20 years of experience in diabetes, hormones, obesity and metabolic medicine.
FAQ
Wegovy questions, answered.
Prescription and dose decisions require medical assessment. Do not copy another person’s dose schedule or use medication supplied for someone else.
Apgujeong Hana Clinic offers medical assessment for Wegovy and other GLP-1-based weight-management treatments. Prescription depends on eligibility, safety, current Korean prescribing requirements and product availability.
Both contain semaglutide, but they are distinct branded products with different approved uses, dose pathways and product information. They should not be treated as automatically interchangeable.
Injectable Wegovy is generally administered once weekly. Use it on the schedule provided by the prescribing doctor and follow the product instructions for missed doses.
No. Wegovy is usually started at a low dose and increased gradually. Starting too high or escalating too quickly may significantly increase digestive side effects.
Individual results vary according to dose, treatment duration, starting weight, medical conditions, food intake, activity and medication tolerance. The clinic does not guarantee a fixed percentage or timeline.
Common effects include nausea, vomiting, diarrhea, constipation, abdominal discomfort, indigestion, bloating, headache, dizziness and fatigue. Contact the clinic when symptoms are persistent or interfere with hydration and nutrition.
Wegovy is not used for weight loss during pregnancy. Tell the doctor when pregnant, breastfeeding, planning pregnancy or using fertility treatment so the medication plan can be reviewed.
Obesity is often managed as a chronic condition, and weight regain can occur after treatment stops. Duration should be discussed individually based on benefit, side effects, health goals, availability and maintenance planning.
Message WhatsApp +82 10-2950-7551, call 02) 3443-7550 or use Naver Booking. Include your age, height, weight, current medicines and relevant medical conditions.
Related Weight Management Services
Explore related GLP-1 and metabolic-health pages.
Considering Wegovy for weight management?
Book an English-friendly eligibility and safety consultation with a board-certified endocrinologist at Apgujeong Hana Clinic in Gangnam.